Researchers examine the association between patient-derived xenograft with recurrence and survival rates in triple negative breast cancer patients.

The clinical study will evaluate MRK's experimental antibody treatment in patients with diabetic macular edema, a major cause of vision loss.

A recent report has highlighted a growing trend among cancer patients in Kenya, with an increasing number turning to traditional medicine instead of...

Data from a late-stage study shows that SMMT's experimental antibody beat Keytruda in a head-to-head setting in treating certain patients with NSCLC.

Supermodel says she is in remission after being diagnosed seven years ago and rejecting some aspects of traditional medicine

BAYRY enrolls the first patient in the phase III SOHO-02 study among treatment-na??ve patients with advanced NSCLC with HER2-activating mutations.

According to two international studies presented at the ESMO Congress 2024, women who breastfeed after receiving treatment for breast cancer,...

American TODAY presenter Jill Martin shared her breast cancer diagnosis in 2023 ahead of a double mastectomy and chemotherapy.

American TODAY presenter Jill Martin shared her breast cancer diagnosis in 2023 ahead of a double mastectomy and chemotherapy.

Doctors advised the model to undergo a mastectomy with radiation, chemotherapy, hormone therapy and a breast reconstruction.